Shield Therapeutics plc (AIM:STX)

London · Delayed Price · Currency is GBP · Price in GBX

4.660

-0.236 (-4.82%)

Sep 11, 2026, 4:35 PM GMT

Shield Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	58.63	49.7	32.18	13.09	5.5	2.06
Revenue Growth	17.95%	54.45%	145.93%	137.95%	167.36%	-85.50%
Gross Profit	30.57	23.04	14.93	4.03	2.46	0.73
Operating Income	-4.05	-10.05	-22.87	-31.33	-31.65	-27.48
Net Income	-10.37	-17.66	-27.18	-33.29	-49.79	-26.65
Earnings Per Share	-0.01	-0.02	-0.03	-0.05	-0.21	-0.13
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	46.69	45.78	29.27	11.57	3.53	0.08
The Netherlands	3.39	2.76	2.14	1.5	1.78	1.23
Canada	0.68	0.83	0.32	-	0.19	-
Japan	-	0.34	0.32	-	-	-
South Korea	-	-	0.12	0.02	0.01	0.74
Total	58.63	49.7	32.18	13.09	5.49	2.06

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8.35	11.62	6.52	13.95	3.4	16.41
Total Debt	24.9	30.14	26.37	20.25	6.79	0.21
Net Cash (Debt)	-16.56	-18.51	-19.85	-6.3	-3.39	16.2
Net Cash Growth	-	-	-	-	-	307.37%
Net Cash Per Share	-0.02	-0.02	-0.03	-0.01	-0.01	0.08

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	1.37	-3.38	-6.77	-37.13	-22.59	-24.73
Capital Expenditures	-0.05	-0.02	-0.04	-0.24	-0.06	-0.5
Free Cash Flow	1.32	-3.4	-6.81	-37.37	-22.66	-25.23
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	52.14%	46.36%	46.39%	30.78%	44.70%	35.48%
Operating Margin	-6.91%	-20.22%	-71.08%	-239.44%	-575.49%	-1336.01%
Pretax Margin	-16.75%	-34.49%	-82.52%	-247.42%	-897.31%	-1310.53%
Profit Margin	-17.69%	-35.52%	-84.47%	-254.44%	-905.42%	-1295.46%
FCF Margin	2.25%	-6.85%	-21.15%	-285.56%	-411.98%	-1226.73%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	113.42	113.42	113.42	113.42	113.42
PS Ratio	1.13	2.83	0.82	5.10	4.01	63.24